Credits: Canva
A cheese brand has recalled one of its products over a serious health risk. Face Rock Creamery LLC has announced a voluntary recall of its Vampire Slayer Garlic Cheddar, according to a recent notice shared by the United States Food and Drug Administration. The decision came after the FDA detected Listeria monocytogenes in the area where the cheese was packed. The cheese is being pulled from shelves due to listeria contamination, which has also been linked to recent deaths in the United States, as reported by The Independent.
Only 16 units of the affected cheese were sold at the Face Rock flagship outlet at 680 2nd St. SE, Bandon, Oregon. Shoppers can identify the recalled product by its UPC code 8 512222 00547 8, according to the FDA.
These six ounce blocks were sold between November 10 at 3:30 p.m. PT and November 13 at 3:30 p.m. PT. Although no illnesses have been confirmed so far, customers who purchased the cheese are advised to discard it or bring it back to the store for a complete refund.
The item under recall is the Vampire Slayer Garlic Cheddar with a use by date of November 4, 2026, and the UPC 8 512222 00547 8. Face Rock Creamery stated that it is committed to strict food safety practices and transparency and that it is cooperating with authorities while taking immediate action to secure its production setting, according to The Independent. As of November 18, the FDA had not received any reports of illness tied to this cheese.
The recall notice on the FDA website explains that listeria infections can be dangerous and may be fatal for young children, older adults, and individuals with weakened immunity. It also states that healthy people might experience short-term problems such as high fever, strong headache, stiffness, nausea, stomach pain and diarrhea. For pregnant women, listeria can lead to miscarriages or stillbirths.
Listeria is a bacteria found in soil, water and animals that can contaminate food and cause listeriosis, a serious infection, as per World Health Organization. It poses a higher risk for pregnant women, newborns, older adults and people with weakened immune systems because it can live and grow even at refrigerator temperatures.
People usually become sick after eating contaminated items such as soft cheeses, deli meats or unpasteurized milk. Symptoms may be mild or flu-like, but the infection can lead to dangerous problems, including meningitis.
In the United States, listeria is the third leading cause of death linked to foodborne illness and is responsible for about 260 deaths each year. Many food products have been recalled in the past few months due to listeria concerns. As per USA Today, six people have died in a multistate outbreak connected to recalled prepared pasta dishes sold at large chains including Albertsons, Kroger, Sprouts Farmers Market and Trader Joe’s.
Federal officials reported at least 27 infections across 18 states, and CNN noted that a pregnant woman lost her fetus after becoming sick.
Symptoms of listeriosis often begin with fever, chills, muscle pain, nausea or diarrhea. In more severe cases, the infection can spread beyond the digestive system and may cause intense headache, stiff neck, confusion, seizures and widespread infection that leads to organ failure. Pregnant women may have only mild flu-like signs, yet the infection can cause serious harm to the developing fetus.
Credits: Gemini
A major claim from China has sparked global curiosity and debate after a Shenzhen-based biotechnology company announced that it has developed a longevity pill capable of significantly slowing ageing.
A biotechnology company in Shenzhen, China, has caught worldwide attention by claiming to have created a pill that could dramatically slow the ageing process. According to the firm, the pill may one day help humans live up to 150 years by targeting ageing at the cellular level.
As per The Independent, Lonvi Biosciences says its formula focuses on ‘zombie cells’—aged cells that refuse to die, causing inflammation and age-related illnesses. Let’s take a closer look at the pill and explore whether this ambitious claim could be possible.
The Shenzhen-based company, part of China’s rapidly growing longevity industry, claims it has produced a pill that could theoretically stretch human life to 150 years. The formula targets so-called “zombie cells”—older cells that resist dying, leading to inflammation and disease associated with ageing. “This is not just another pill. This is the Holy Grail,” said CEO Ip Zhu, calling the capsule a breakthrough that could make extreme longevity achievable. The main ingredient comes from grape seeds and has shown in lab studies to extend lifespan in animals by delaying age-related diseases. Lonvi’s researchers suggest that taking the pill in adulthood could push life expectancy past 120, while starting from birth could surpass 150.
The pill contains procyanidin C1 (PCC1), a compound extracted from grape seeds. In experiments with mice, Lonvi claims the treatment increased overall lifespan by 9.4%, with a remarkable 64% improvement when dosing started from the very beginning. Lyu Qinghua, Lonvi’s chief technology officer, told The New York Times that reaching 150 is “definitely realistic” and could be possible “within a few years.”
China has made anti-ageing research a national priority, with President Xi Jinping reportedly discussing it with Russian President Vladimir Putin. Anti-ageing research, combined with AI and biotech, has quickly moved from niche interest to mainstream focus in the country.
A study in Nature Metabolism showed that procyanidin C1 from grape seed extract successfully extended both the lifespan and health span of mice, paving the way for future clinical trials.
Cellular senescence plays a key role in ageing, occurring when cells can no longer perform their functions. In recent years, researchers have identified drugs called senolytics, which can eliminate these senescent cells in the lab and in animal studies. This approach is an important step toward reducing age-related chronic diseases and could play a critical role in extending lifespan.
While the company’s claims have not yet been tested in human trials, scientists believe the approach holds promise for extending life. Lonvi’s researchers say the PCC1 pill can boost cellular health, delay deterioration, and maintain energy production over time. They suggest that when combined with a healthy lifestyle, the pill could help people live beyond 100, and possibly even past 120, while also reducing diseases linked to ageing.
Credits: Canva
A new global study in The Lancet’s eClinicalMedicine has drawn serious concern about the sharp rise of antimicrobial resistance (AMR) in India, placing the country at the centre of what many specialists now consider a fast-moving superbug crisis. The research, titled Preprocedural screening for multidrug-resistant organisms in endoscopic retrograde cholangiopancreatography: an international, multicentre, cross-sectional observational study, shows that Indian patients had the highest worldwide rates of multidrug-resistant organisms (MDROs) among those undergoing a common endoscopic procedure.
These numbers far exceed the levels documented in Italy, the United States and the Netherlands.
A superbug is a strain of bacteria that no longer responds to one or more groups of antibiotics that previously worked well. This can happen through enzyme production such as carbapenemases, changes in drug targets, increased pumping out of drugs or shifts in the cell wall that block antibiotics from entering, as per National Institute of Health. When bacteria gain resistance to several antibiotic classes, the list of possible treatments becomes very small. Such resistance makes infections tougher to manage because routine medicines no longer work, leading to more severe illness.
Also Read: Ultra-Processed Food Is Harming Your Heart, Liver And Brain, Warns New Lancet Study
The recent Lancet paper used screening of patients scheduled for endoscopic retrograde cholangiopancreatography (ERCP), a frequently performed procedure, to highlight how widespread MDROs already are among Indian patients even before major interventions.
The study assessed more than 1,200 patients across India, Italy, the Netherlands and the United States. Among them, 83.1 per cent of Indian patients carried at least one superbug, a figure far higher than those in the other countries.
A few resistant pathogens account for most of the problem in the country, as per The Lancet Study:
Also Read: The Kessler Twins Die By Assisted Suicide in Germany; How It Differs From Euthanasia
Enterobacterales, especially Klebsiella pneumoniae and Escherichia coli: These cause a large share of urinary tract infections, bloodstream infections and hospital-related illnesses. The study noted that nearly 70.2 per cent of Indian patients carried ESBL-producing strains.
Carbapenem-resistant Gram-negatives (CRGNs): India’s carbapenem-resistance rate for key pathogens was around 23.5 per cent, signalling that even some last-resort drugs fail against these infections.
Acinetobacter baumannii and Pseudomonas aeruginosa: These are common in intensive care units, often highly resistant and linked with ventilator-associated pneumonia. Surveillance in India shows very high resistance levels in both.
Staphylococcus aureus (MRSA, or methicillin-resistant Staph. aureus): This remains an established cause of surgical site and hospital-acquired infections.
Together, these organisms form part of the “ESKAPE” group (Enterococcus, Staph. aureus, Klebsiella, Acinetobacter, Pseudomonas and Enterobacter), which represents the central challenge in antibiotic resistance. India’s unusually high carriage and infection rates of these pathogens increase the threat both in hospitals and in the community, as highlighted in The Lancet study.
Resistance may be inevitable, yet it can still be controlled. The new findings make it clear that India cannot afford further delays. Antibiotic resistance is no longer a niche concern. With such high carriage levels, every hospital visit becomes a potential source of spread and every procedure carries added risk. Officials often speak about “containing resistance,” but the timeframe to act is shrinking. Without stronger antibiotic stewardship, timely diagnostics and firm infection-control practices, the country may lose access to many dependable first-line antibiotics for everyday infections, undoing years of medical progress.
Credits: Canva
Ultra-processed food (UPF) is linked to harm in every major organ system of the human body and poses a seismic threat to global health, according to the world’s largest review, as per The Lancet Study. The scientists, including the Brazilian professor who coined the term with colleagues around 15 years ago, argue that UPFs are now increasingly common worldwide and linked to a decline in diet quality and a number of diseases, from obesity to cancer.
Ultra processed foods are factory-made products built from refined ingredients rather than whole foods. They usually contain additives such as preservatives, flavor enhancers, stabilizers or artificial colors that you would not use in an ordinary kitchen. Items like soft drinks, chips, packaged sweets and heat-and-eat meals fall into this group. They are created for convenience and taste, last a long time on shelves and often provide little real nourishment. In many cases, the final product no longer resembles the raw ingredients it came from.
Also Read: The Kessler Twins Die By Assisted Suicide in Germany; How It Differs From Euthanasia
The growing presence of ultra-processed foods in daily diets is now tied to serious health risks. A group of three papers published in The Lancet examined existing evidence and found clear links between UPFs and many non-communicable diseases. A report by The Guardian noted that UPFs are associated with harm across major organ systems. The review described these foods as a significant public health danger. It also stressed that worsening diets have become an urgent concern. The Lancet team called for stronger policies and wider public action to reduce the reach of UPFs and to make fresh and minimally processed foods easier to access.
The review, which combined findings from three papers, comes at a time when millions rely on UPF products such as ready meals, packaged cereals, protein bars, fizzy drinks and fast food. In both the UK and the US, more than half of a typical person’s daily intake now comes from UPFs. Among younger people and those from economically strained or underserved communities, a diet made up of nearly 80 percent UPF is common, according to the study.
Also Read: Chris Hemsworth's Father Has Alzheimer’s, and Tests Show He Carries the Risk Gene Too
UPFs are replacing fresh foods for children and adults across all regions. These products are linked with higher chances of obesity, type 2 diabetes, heart disease and depression, according to the Lancet study as per the Guardian report.
Professor Carlos Monteiro, a public health nutrition expert at the University of Sao Paulo and a contributor to The Lancet series, said the findings underline the need for immediate measures to address UPF consumption. He told The Guardian that rising intake of ultra-processed foods is changing diets everywhere, pushing aside fresh and minimally processed meals. The evidence from the first paper in the series pointed out that this shift from traditional food habits toward UPFs is playing a major role in the rise of many long-term diet-related illnesses around the world.
The second paper in the series outlined possible steps to reduce UPF production, marketing and intake. The third paper explained that large global corporations are steering the spread of UPFs, rather than individual choices, according to The Guardian coverage. Experts who were not part of the research welcomed the findings while also noting that more studies are needed. They cautioned that links do not always prove direct cause.
The researchers suggested that UPF ingredients should be clearly listed on the front of food packages. They also recommended warnings for high sugar, salt and saturated fat. They said this clarity is important because UPFs have become part of ordinary eating habits. From common breakfast cereals to packaged juices sold as organic, these products are everywhere.
Professor Marion Nestle of New York University said that improving diets across countries will require plans suited to each region’s needs and the level to which UPFs have become part of routine meals. She added that priorities may vary but action is necessary in all places to regulate ultra-processed foods, along with existing efforts to limit high fat, salt and sugar levels.
© 2024 Bennett, Coleman & Company Limited